You have 9 free searches left this month | to do more

infliximab

Infliximab is a drug used to treat Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, and other conditions. Infliximab is being actively studied in 41 studies and prior, has been studied in 87.

Top SponsorsTop SitesTop Investigators
Centocor, Inc.Hopital BeaujonAndrew H Miller
Merck Sharp & Dohme Corp.Hopital Saint LouisLissy de Ridder
Assistance Publique - Hopitaux de ParisNational Institutes of Health Clinical Center, 9000 Rockville PikeYing HUANG
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
X
Active, not recruiting
  • Uveitis
  • Infliximab
  • infliximab
  • (no location specified)
2021-04-01
Apr 1, 2021
C
Not yet recruiting
  • Crohn Disease
  • +3 more
  • Infliximab and immunosuppressives
  • Infliximab
  • (no location specified)
2021-09-05
Sep 5, 2021
U
Not yet recruiting
  • Inflammatory Bowel Diseases
  • Infliximab
  • Leuven, Vlaanderen, Belgium
    UZ Leuven
2021-07-29
Jul 29, 2021
C
Completed
  • Arthritis, Rheumatoid
  • Infliximab
  • Chiba, Japan
    Chiba University Hospital
2021-01-15
Jan 15, 2021
S
Terminated
  • Ulcerative Colitis
  • Infliximab
  • Petaẖ Tiqwa, Israel
    Schenider Children's Medical Center
2021-09-25
Sep 25, 2021
A
Recruiting
  • Ulcerative Colitis
  • Infliximab
  • Melbourne, Victoria, Australia
    Austin Health
2021-07-19
Jul 19, 2021
T
Completed
  • COVID-19
  • Infliximab
  • Boston, Massachusetts
    Tufts Medical Center
2021-02-17
Feb 17, 2021
M
Not yet recruiting
  • Metastatic Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-08-29
Aug 29, 2021
J
Recruiting
  • COVID-19
  • Infliximab
  • Standard of Care
  • Jena, Germany
    Jena University Hospital
2021-07-06
Jul 6, 2021
C
Not yet recruiting
  • Ulcerative Colitis
  • +2 more
  • (no location specified)
2021-08-05
Aug 5, 2021
M
Recruiting
  • Crohn Disease
  • Infliximab
  • Boston, Massachusetts
    MassGeneral for Children
2020-11-30
Nov 30, 2020
T
Completed
  • Rheumatoid Arthritis
  • Infliximab
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
2021-10-08
Oct 8, 2021
B
Not yet recruiting
  • Crohn Disease
  • Infliximab
  • New York, New York
    Mount Sinai
2021-07-19
Jul 19, 2021
J
Recruiting
  • Crohn Disease
  • Infliximab
  • Beijing, China
  • +5 more
2021-09-28
Sep 28, 2021
U
Completed
  • Bipolar Depression
  • Infliximab
  • Saline
  • Palo Alto, California
  • +1 more
2021-07-07
Jul 7, 2021
H
Recruiting
  • Idiopathic Refractory Scleritis
  • Lyon, France
    Hospices Civils de Lyon - Hopital de la Croix Rousse
2020-07-09
Jul 9, 2020
A
Active, not recruiting
  • Extrathoracic Sarcoidosis
  • Infliximab
  • Placebo
  • Bobigny, France
  • +9 more
2021-08-27
Aug 27, 2021
S
Recruiting
  • Moderate to Severe Ulcerative Colitis
  • Guandong, China
    The Sixth Affiliated Hospital, Sun Yat-sen University
2021-05-26
May 26, 2021
M
Recruiting
  • Melanoma Stage III
  • +3 more
  • Infliximab
  • +2 more
  • Boston, Massachusetts
  • +1 more
2020-08-31
Aug 31, 2020
E
Active, not recruiting
  • Crohn's Disease
  • Infliximab
  • +3 more
  • Brussels, Belgium
  • +12 more
2021-08-18
Aug 18, 2021
K
Completed
  • Rheumatoid Arthritis
  • Infliximab
  • Sulfasalazine + Hydroxychloroquine
  • Stockholm, Sweden
    Karolinska Institutet, Department of Medicine Solna, Clinical Ep
2021-09-22
Sep 22, 2021
S
Completed
  • Crohn Disease
  • Infliximab
  • Wenzhou, Zhejiang, China
    SAHWenzhouMU
2020-02-13
Feb 13, 2020
U
Recruiting
  • Aneurysm
  • +3 more
  • Infliximab
  • San Francisco, California
    UCSF Medical Center
2020-02-28
Feb 28, 2020